Discuss the latest strategies to harness the immune system for the development of innovative therapeutics
Featuring 200+ presentations, the event brings together over 500 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.
The 2024 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below were the key speakers for Immuno US 2023
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.